These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2849670)
1. Voltage-dependent binding of dihydropyridine calcium channel blockers to guinea pig ventricular myocytes. Kamp TJ; Sanguinetti MC; Miller RJ J Pharmacol Exp Ther; 1988 Dec; 247(3):1240-7. PubMed ID: 2849670 [TBL] [Abstract][Full Text] [Related]
2. Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells. Greenberg DA; Carpenter CL; Messing RO J Pharmacol Exp Ther; 1986 Sep; 238(3):1021-7. PubMed ID: 2427685 [TBL] [Abstract][Full Text] [Related]
3. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes. Wei XY; Rutledge A; Triggle DJ Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561 [TBL] [Abstract][Full Text] [Related]
4. Dihydropyridine binding and calcium channel function in clonal rat adrenal medullary tumor cells. Kunze DL; Hamilton SL; Hawkes MJ; Brown AM Mol Pharmacol; 1987 Apr; 31(4):401-9. PubMed ID: 2437436 [TBL] [Abstract][Full Text] [Related]
5. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization. Liu J; Bangalore R; Rutledge A; Triggle DJ Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413 [TBL] [Abstract][Full Text] [Related]
6. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes. Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031 [TBL] [Abstract][Full Text] [Related]
7. Depolarization of chick myotubes triggers the appearance of (+)-[3H]PN 200-110-binding sites. Pauwels PJ; Van Assouw HP; Leysen JE Mol Pharmacol; 1987 Dec; 32(6):785-91. PubMed ID: 2826992 [TBL] [Abstract][Full Text] [Related]
8. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance. Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965 [TBL] [Abstract][Full Text] [Related]
9. The effect of oxygen free radicals on calcium current and dihydropyridine binding sites in guinea-pig ventricular myocytes. Guerra L; Cerbai E; Gessi S; Borea PA; Mugelli A Br J Pharmacol; 1996 Jul; 118(5):1278-84. PubMed ID: 8818354 [TBL] [Abstract][Full Text] [Related]
10. Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle. Morel N; Godfraind T J Pharmacol Exp Ther; 1987 Nov; 243(2):711-5. PubMed ID: 2824756 [TBL] [Abstract][Full Text] [Related]
11. Characterization of 1,4, dihydropyridine calcium channel binding sites in the human prostate. Rosenthal E; Shapiro E; Lepor H J Urol; 1990 Dec; 144(6):1539-42. PubMed ID: 1700163 [TBL] [Abstract][Full Text] [Related]
12. Calcium channel agonist and antagonist binding in a highly enriched sarcolemma preparation obtained from canine ventricle. Rampe D; Poder T; Zhao ZY; Schilling WP J Cardiovasc Pharmacol; 1989 Apr; 13(4):547-56. PubMed ID: 2470991 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine. Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512 [TBL] [Abstract][Full Text] [Related]
14. Effect of inorganic calcium channel blockers on dihydropyridine binding to cardiac sarcolemma. Schilling WP; Zaher MC; Rampe D Mol Pharmacol; 1990 Jan; 37(1):80-9. PubMed ID: 2137194 [TBL] [Abstract][Full Text] [Related]
15. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla. Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669 [TBL] [Abstract][Full Text] [Related]
17. Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes. Bolger GT; Marcus KA; Daly JW; Skolnick P J Pharmacol Exp Ther; 1987 Mar; 240(3):922-30. PubMed ID: 3031279 [TBL] [Abstract][Full Text] [Related]
18. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules. Murphy BJ; Tuana BS Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734 [TBL] [Abstract][Full Text] [Related]
19. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength. Bellemann P; Ferry D; Lübbecke F; Glossmann H Arzneimittelforschung; 1982; 32(4):361-3. PubMed ID: 7201804 [TBL] [Abstract][Full Text] [Related]
20. Evidence for distinct calcium channel agonist and antagonist binding sites in intact cultured embryonic chick ventricular cells. Lee RT; Smith TW; Marsh JD Circ Res; 1987 May; 60(5):683-91. PubMed ID: 2439230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]